President Trump announced the University of Miami has transferred its original 1994 Ibogaine application to the administration, potentially accelerating approval for psychedelic treatment of veterans.
Ibogaine, a psychoactive compound, has shown promise in addiction treatment. Studies suggest a single dose eliminates opiate addiction in over 80% of patients, rising to 90% with two doses. Over 5 million Americans currently struggle with opiate addiction.
The move follows Trump's April executive order advancing psychedelic research and treatment options. The 30-year-old application could bypass years of regulatory groundwork, fast-tracking clinical pathways for veteran care programs.
Ibogaine, a psychoactive compound, has shown promise in addiction treatment. Studies suggest a single dose eliminates opiate addiction in over 80% of patients, rising to 90% with two doses. Over 5 million Americans currently struggle with opiate addiction.
The move follows Trump's April executive order advancing psychedelic research and treatment options. The 30-year-old application could bypass years of regulatory groundwork, fast-tracking clinical pathways for veteran care programs.